𝔖 Bobbio Scriptorium
✦   LIBER   ✦

State of stem cell pools in experimental diabetes mellitus

✍ Scribed by E. D. Goldberg; A. M. Dygai; V. V. Zhdanov; G. N. Zyuz’kov; T. I. Fomina; L. A. Ermolaeva; L. A. Gur’yantseva; T. Yu. Khrichkova; T. V. Vetoshkina


Publisher
Springer US
Year
2006
Tongue
English
Weight
392 KB
Volume
142
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Mesenchymal stem cells accelerate bone a
✍ Eric A. Breitbart; Sharonda Meade; Vikrant Azad; Sloane Yeh; Loay Al-Zube; Yee-S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 355 KB

## Abstract Allograft (Allo) incorporation in the presence of a systemic disease like diabetes mellitus (DM) is becoming a major issue in the orthopedic community. Mesenchymal stem cells (MSC) are multipotent stem cells that may be derived from adult, whole bone marrow and have been shown to induce

The study of renin–angiotensin–aldostero
✍ B. Üstündag; M. Cay; M. Naziroglu; N. Dilsiz; M. J. C. Crabbe; N. Ilhan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

It is generally accepted that hypertension and other vascular pathologies increase in diabetes mellitus (DM) patients as a result of the renin±angiotensin±aldosterone (RAA) system. In this study, changes in the renin-angiotensinaldosterone (RAA) system level was determined in Streptozotocin (STZ)-in

Long-term studies of pancreas allotransp
✍ Dr. Sun Lee; Michael H. Scott; Diane Yancey; Jennifer Allen; Eil Sung Chang; Fra 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

Pancreaticoduodenal (PD) allografts (Brown Norway-alloxan-diabetic rats, n = 190) were treated with cyclosporin A (Cy-A) 10 mg/kg/daily and compared with nondiabetics with Cy-A treatment (n = 55), diabetics (n = 50), and diabetics with Cy-A treatment (n = 45). Body weight, blood sugar, blood insulin